We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.89%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+6.16%
1 Year Est. Return
+40.89%
3 Year Est. Return
+115.82%
5 Year Est. Return
+132.07%
10 Year Est. Return
+517.81%
AUM
$109B
AUM Growth
+$10.4B
Cap. Flow
+$4.43B
Cap. Flow %
4.04%
Top 10 Hldgs %
18.72%
Holding
8,634
New
1,445
Increased
2,647
Reduced
3,047
Closed
1,267
Avg Time Held Equity + Options
6.9 quarters
Top 10 Avg Time Held Equity + Options
5.6 quarters
Top 20 Avg Time Held Equity + Options
5 quarters
Avg Time Held Equity only
4.8 quarters
Top 10 Avg Time Held Equity only
1.1 quarters
Top 20 Avg Time Held Equity only
1.1 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 56.22%
2 Technology 7.41%
3 Consumer Discretionary 6.04%
4 Financials 5.89%
5 Industrials 4.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
GPI icon
3951
CALL
Group 1 Automotive
GPI
$2.76B
$926K ﹤0.01%
12,500
-4,100
-25% -$321K
2013 Q2
15 quarters
GFI icon
3952
PUT
Gold Fields
GFI
$31.3B
$925K ﹤0.01%
261,900
-155,600
-37% -$526K
2016 Q2
3 quarters
TVRD
3953
Tvardi Therapeutics
TVRD
$14.5M
$924K ﹤0.01%
1,396
+1,072
+331% +$573K
2016 Q3
2 quarters
CENX icon
3954
Century Aluminum
CENX
$3.55B
$923K ﹤0.01%
72,765
-865,562
-92% -$11.5M
2016 Q2
3 quarters
CIVI
3955
DELISTED
Civitas Solutions, Inc.
CIVI
$923K ﹤0.01%
50,320
-12,528
-20% -$232K
2014 Q3
10 quarters
WPZ
3956
CALL
DELISTED
Williams Partners L.P.
WPZ
$923K ﹤0.01%
22,600
+7,000
+45% +$281K
2016 Q1
4 quarters
TAHO
3957
DELISTED
Tahoe Resources Inc
TAHO
$922K ﹤0.01%
114,846
+47,810
+71% +$412K
2014 Q2
11 quarters
ARRY
3958
PUT
DELISTED
Array Biopharma Inc
ARRY
$921K ﹤0.01%
103,000
+44,300
+75% +$471K
2013 Q4
13 quarters
JO
3959
CALL
DELISTED
iPath Bloomberg Coffee Subindex Total Return ETN due June 24, 2038
JO
$921K ﹤0.01%
47,400
+16,100
+51% +$331K
2016 Q1
4 quarters
TECD
3960
CALL
DELISTED
Tech Data Corp
TECD
$920K ﹤0.01%
9,800
+5,000
+104% +$443K
2013 Q2
15 quarters
AEIS icon
3961
PUT
Advanced Energy
AEIS
$11.7B
$919K ﹤0.01%
13,400
+8,200
+158% +$507K
2016 Q4
1 quarter
SQQQ icon
3962
CALL
ProShares UltraPro Short QQQ
SQQQ
$1.96B
$919K ﹤0.01%
10
-8
-44% -$836K
2016 Q3
2 quarters
NUVA
3963
PUT
DELISTED
NuVasive, Inc.
NUVA
$919K ﹤0.01%
12,300
-3,200
-21% -$232K
2016 Q2
3 quarters
WLK icon
3964
CALL
Westlake Corp
WLK
$7.76B
$918K ﹤0.01%
13,900
+5,500
+65% +$348K
2013 Q2
15 quarters
EXPD icon
3965
Expeditors International
EXPD
$24.9B
$917K ﹤0.01%
+16,229
New +$890K
2017 Q1
0 quarters
SOXX icon
3966
CALL
iShares Semiconductor ETF
SOXX
$49B
$917K ﹤0.01%
+20,100
New +$877K
2017 Q1
0 quarters
CGNX icon
3967
CALL
Cognex
CGNX
$10.3B
$915K ﹤0.01%
21,800
+8,800
+68% +$322K
2013 Q2
15 quarters
CSGP icon
3968
CoStar Group
CSGP
$11.2B
$914K ﹤0.01%
44,090
-324,290
-88% -$6.59M
2015 Q4
5 quarters
OHI icon
3969
PUT
Omega Healthcare
OHI
$13.3B
$914K ﹤0.01%
27,700
+4,100
+17% +$132K
2016 Q2
3 quarters
XYL icon
3970
CALL
Xylem
XYL
$23.9B
$914K ﹤0.01%
18,200
-2,200
-11% -$107K
2013 Q2
15 quarters
SIR
3971
DELISTED
SELECT INCOME REIT
SIR
$914K ﹤0.01%
80,587
-344,167
-81% -$3.87M
2013 Q3
14 quarters
CYH icon
3972
PUT
Community Health Systems
CYH
$386M
$913K ﹤0.01%
102,900
+5,300
+5% +$41.3K
2013 Q2
15 quarters
DGX icon
3973
PUT
Quest Diagnostics
DGX
$25.1B
$913K ﹤0.01%
9,300
-11,800
-56% -$1.12M
2013 Q2
15 quarters
SA
3974
PUT
Seabridge Gold
SA
$2.86B
$913K ﹤0.01%
83,000
+46,300
+126% +$481K
2013 Q2
15 quarters
PRI icon
3975
CALL
Primerica
PRI
$8.44B
$912K ﹤0.01%
11,100
-7,800
-41% -$608K
2016 Q4
1 quarter

Similar funds

Citadel Advisors's Q1 2017 Portfolio in Review

As of Q1 2017, Citadel Advisors held 8,634 positions worth $109B, up 11% from $99B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Citadel Advisors deployed $4.43B of net new capital in Q1 2017, opening 1,445 new positions and adding to 2,647 existing holdings. Its largest new stake was Meta Platforms (Facebook): 4,289,917 shares worth $609M.

By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, down from 63% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $482M trimmed.

  • Citadel Advisors's largest Q1 2017 buy was Meta Platforms (Facebook): 4,289,917 shares worth $609M.
  • Citadel Advisors added most to Microsoft in Q1 2017, an estimated $529M increase.
  • Citadel Advisors's biggest Q1 2017 reduction was Alphabet (Google) Class A, cutting an estimated $482M.
  • Citadel Advisors fully exited Celgene Corp in Q1 2017, selling an estimated $341M.
  • Citadel Advisors's ten largest holdings make up 19% of its $109B portfolio in Q1 2017.
  • Citadel Advisors opened 1,445 new positions and closed 1,267 in Q1 2017.
  • Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $109B.

Based on Citadel Advisors's 13F filing for Q1 2017, filed 12 May 2017.